Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8S3R

HUMAN PI3KDELTA IN COMPLEX WITH PYRIDAZINONE INHIBITOR 7

This is a non-PDB format compatible entry.
Summary for 8S3R
Entry DOI10.2210/pdb8s3r/pdb
DescriptorPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, Phosphatidylinositol 3-kinase regulatory subunit alpha, 5-[(1~{S})-1-[4-azanyl-3-(5-oxidanylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-4-cyclopentyl-2-(phenylmethyl)pyridazin-3-one, ... (4 entities in total)
Functional Keywordspi3kdelta kinase, pi3kdelta kinase inhibitor, transferase
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight137988.76
Authors
Pala, D.,Bruno, P.,Capelli, A.M.,Biagetti, M. (deposition date: 2024-02-20, release date: 2024-07-03, Last modification date: 2024-07-24)
Primary citationBruno, P.,Micoli, A.,Corsi, M.,Pala, D.,Guariento, S.,Fiorelli, C.,Ronchi, P.,Fioni, A.,Gallo, P.M.,Marenghi, G.,Bertolini, S.,Capacchi, S.,Mileo, V.,Biagetti, M.,Capelli, A.M.
Discovery and Optimization of Pyridazinones as PI3K delta Selective Inhibitors for Administration by Inhalation.
J.Med.Chem., 67:11103-11124, 2024
Cited by
PubMed Abstract: A hit-to-lead campaign pursuing the identification of novel inhalant small-molecule phosphatidylinositol 3-kinase (PI3K) inhibitors for the treatment of inflammatory respiratory diseases is disclosed. A synthetically versatile pyridazin-3(2)-one scaffold was designed, and three exit vectors on the core moiety were used to explore chemical diversity and optimize pharmacological and absorption, distribution, metabolism, and excretion (ADME) properties. Desired modulation of PI3Kδ selectivity and cellular potency as well as ADME properties in view of administration by inhalation was achieved. Intratracheal administration of lead compound resulted in a promising pharmacokinetic profile, thus demonstrating that the optimization strategy of profiles successfully translated to an setting.
PubMed: 38907711
DOI: 10.1021/acs.jmedchem.4c00610
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.28 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon